Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
11 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
16 Apr 24
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Departure of Directors or Certain Officers
26 Mar 24
8-K
Regulation FD Disclosure
22 Feb 24
8-K
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
15 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 23
8-K
Regulation FD Disclosure
21 Jun 23
8-K
Regulation FD Disclosure
17 Apr 23
8-K
Regulation FD Disclosure
9 Jan 23
8-K
Other Events
12 Dec 22
Registration and prospectus
D
$5.00 mm in debt / securities to be acquired, sold $317.50 k, 2 investors
28 Oct 22
D
$5M in debt / securities to be acquired, sold $200K, 1 investor
30 Aug 21
25-NSE
Exchange delisting
21 Apr 17
25-NSE
Exchange delisting
21 Apr 17
424B3
Prospectus supplement
6 Mar 17
424B3
Prospectus supplement
21 Feb 17
424B3
Prospectus supplement
9 Feb 17
424B4
Prospectus supplement with pricing info
31 Jan 17
S-1/A
IPO registration (amended)
26 Jan 17
S-1/A
IPO registration (amended)
19 Jan 17
Proxies
PRE 14A
Preliminary proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Jun 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
PRE 14A
Preliminary proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Jun 22
DEFA14A
Additional proxy soliciting materials
6 Jun 22
DEFA14A
Additional proxy soliciting materials
26 May 22
DEFA14A
Additional proxy soliciting materials
19 May 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
Other
CORRESP
Correspondence with SEC
27 Jan 17
EFFECT
Notice of effectiveness
27 Jan 17
CORRESP
Correspondence with SEC
25 Jan 17
UPLOAD
Letter from SEC
19 Dec 16
CORRESP
Correspondence with SEC
19 Dec 16
CORRESP
Correspondence with SEC
22 Nov 16
UPLOAD
Letter from SEC
16 Nov 16
UPLOAD
Letter from SEC
1 Nov 16
CORRESP
Correspondence with SEC
1 Nov 16
UPLOAD
Letter from SEC
24 Oct 16